These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 9276154)
1. Potent, long-acting bradykinin antagonists for a wide range of applications. Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS Can J Physiol Pharmacol; 1997 Jun; 75(6):719-24. PubMed ID: 9276154 [TBL] [Abstract][Full Text] [Related]
2. Potent, long-acting, orally-active bradykinin antagonists for a wide range of applications. Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS Immunopharmacology; 1997 Jun; 36(2-3):167-72. PubMed ID: 9228542 [TBL] [Abstract][Full Text] [Related]
3. A new generation of bradykinin antagonists. Stewart JM; Gera L; Hanson W; Zuzack JS; Burkard M; McCullough R; Whalley ET Immunopharmacology; 1996 Jun; 33(1-3):51-60. PubMed ID: 8856115 [TBL] [Abstract][Full Text] [Related]
4. Bradykinin-related compounds as new drugs for cancer and inflammation. Stewart JM; Gera L; Chan DC; Bunn PA; York EJ; Simkeviciene V; Helfrich B Can J Physiol Pharmacol; 2002 Apr; 80(4):275-80. PubMed ID: 12025961 [TBL] [Abstract][Full Text] [Related]
5. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor. Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513 [TBL] [Abstract][Full Text] [Related]
6. Correlation of secondary structures of bradykinin B1 receptor antagonists with their activity. Miskolzie M; Gera L; Stewart JM; Kotovych G J Biomol Struct Dyn; 2002 Feb; 19(4):585-93. PubMed ID: 11843620 [TBL] [Abstract][Full Text] [Related]
7. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists. Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332 [TBL] [Abstract][Full Text] [Related]
8. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity. Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478 [TBL] [Abstract][Full Text] [Related]
9. Bradykinin receptor antagonists type 2 attenuate the inflammatory changes in peptidoglycan-induced acute arthritis in the Lewis rat. Uknis AB; DeLa Cadena RA; Janardham R; Sartor RB; Whalley ET; Colman RW Inflamm Res; 2001 Mar; 50(3):149-55. PubMed ID: 11339503 [TBL] [Abstract][Full Text] [Related]
10. Characterization of bradykinin receptors in a human osteoblastic cell line. Brechter AB; Lerner UH Regul Pept; 2002 Jan; 103(1):39-51. PubMed ID: 11738247 [TBL] [Abstract][Full Text] [Related]
11. In vivo pharmacological profile of novel, potent, stable BK antagonists at B1 and B2 receptors. Hanson WL; McCullough RG; Selig WM; Wieczorek M; Ross S; Whalley ET; Stewart JM; Gera L Immunopharmacology; 1996 Jun; 33(1-3):191-3. PubMed ID: 8856147 [No Abstract] [Full Text] [Related]
12. Comparative profile of novel potent bradykinin antagonists at human B1 and B2 receptors. Burkard M; Zuzack JS; Jones S; Francis M; Whalley ET; Stewart JM; Gera L Immunopharmacology; 1996 Jun; 33(1-3):186-90. PubMed ID: 8856146 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate. Srinivasan D; Burbach LR; Daniels DV; Ford AP; Bhattacharya A Br J Pharmacol; 2004 May; 142(2):297-304. PubMed ID: 15155537 [TBL] [Abstract][Full Text] [Related]
14. A single position in the third transmembrane domains of the human B1 and B2 bradykinin receptors is adjacent to and discriminates between the C-terminal residues of subtype-selective ligands. Fathy DB; Mathis SA; Leeb T; Leeb-Lundberg LM J Biol Chem; 1998 May; 273(20):12210-8. PubMed ID: 9575169 [TBL] [Abstract][Full Text] [Related]
15. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation. Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739 [TBL] [Abstract][Full Text] [Related]
16. A new class of pseudopeptide antagonists of the kinin B1 receptor containing alkyl spacers. Galoppini C; Meini S; Tancredi M; Di Fenza A; Triolo A; Quartara L; Maggi CA; Formaggio F; Toniolo C; Mazzucco S; Papini A; Rovero P J Med Chem; 1999 Feb; 42(3):409-14. PubMed ID: 9986712 [TBL] [Abstract][Full Text] [Related]
17. Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958. Gera L; Stewart JM; Fortin JP; Morissette G; Marceau F Int Immunopharmacol; 2008 Feb; 8(2):289-92. PubMed ID: 18182242 [TBL] [Abstract][Full Text] [Related]